阿尔帕卡斯 (AlPaCas):通过原空间邻动机 (PAM) 方法对异位基因特异性CRISPR基因进行编辑
Serena Rosignoli1, Elisa Lustrino1, Alessio Conci2
1Department of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, Rome 00185, Italy.
Nucleic acids research
|May 25, 2024
概括
AlPaCas网络服务器通过识别CRISPR-Cas向的特定单核酸变体 (SNVs) 来帮助基因治疗. 这种工具有助于精确编辑引起疾病的突变,同时保持健康的基因等位基因.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 主要遗传遗传性疾病需要精确的基因编辑策略.
- 克里斯普尔-卡斯系统提供了纠正单核酸变异 (SNVs) 的潜力,包括主导突变.
- 在基因组编辑中,区分致病性SNV与野生类型等位基因是一个重大挑战.
研究的目的:
- 开发一种自动化工具,用于识别SNV衍生的PAMs,以针对异位基因的特定目标.
- 为了促进基因疾病中突变基因的精确破坏或编辑.
- 为了提高CRISPR-Cas酶对病原性SNVs的选择性.
主要方法:
- 开发AlPaCas (将患者与Cas对齐) 网络服务器,这是一个自动化管道.
- 基于SNV衍生Protospacer相邻基因 (PAMs) 的序列识别和结构分析.
- 利用基因/SNV输入来识别PAM,列出兼容的Cas酶,并提出Cas工程策略.
主要成果:
- AlPaCas成功地识别了SNV衍生的PAMs,从而实现了异位基因特异性向.
- 网络服务器列出了识别特定SNV的Cas酶.
- 阿尔帕卡斯 (AlPaCas) 提出了 Cas 酶的工程方法,以提高 SNV 衍生的 PAM 的选择性.
结论:
- AlPaCas是推动基因组编辑的宝贵工具,特别是在SNV引起的遗传疾病中.
- 识别等位基因特异性标的能力提高了基因疗法的精度.
- AlPaCas是免费访问的,促进在遗传研究和治疗开发中的更广泛应用.
相关概念视频
CRISPR
50.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.6K
Conservative Site-specific Recombination and Phase Variation
6.0K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.0K


